darzalex - SERP Analysis

https://www.darzalex.com/

https://www.darzalexhcp.com/

https://www.myeloma.org/darzalex-daratumumab

https://en.wikipedia.org/wiki/Daratumumab

https://www.aetna.com/cpb/medical/data/900_999/0904.html

https://www.ema.europa.eu/en/documents/product-information/darzalex-epar-product-information_en.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761036s044lbl.pdf

https://www.jnj.com/media-center/press-releases/darzalex-faspro-daratumumab-and-hyaluronidase-fihj-shows-51-percent-reduction-in-risk-of-progression-to-active-multiple-myeloma-for-patients-with-high-risk-smoldering-multiple-myeloma

https://www.drugs.com/darzalex.html

https://www.myeloma.org/resource-library/understanding-darzalex-faspro

https://www.darzalexhcp.com/for-APPs-and-nurses/

https://www.jnj.com/media-center/press-releases/janssen-submits-application-for-darzalex-daratumumab-combination-therapy-to-u-s-fda-for-newly-diagnosed-transplant-eligible-patients-with-multiple-myeloma

https://www.fda.gov/drugs/resources-information-approved-drugs/daratumumab-darzalex

https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/DARZALEX%2BFaspro-pi.pdf

https://www.cancer.gov/news-events/cancer-currents-blog/2025/fda-daratumumab-isatuximab-newly-diagnosed-myeloma

https://www.janssencarepath.com/patient/darzalex/withme/cost-support/

https://reference.medscape.com/drug/darzalex-daratumumab-1000063

https://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4bb241af-4299-4373-8762-2d6709515db0

https://www.cda-amc.ca/daratumumab-1

https://www.webmd.com/drugs/2/drug-170456/daratumumab-intravenous/details

https://www.medicalnewstoday.com/articles/drugs-darzalex-for-multiple-myeloma

https://www.medicines.org.uk/emc/product/11488/smpc

https://www.youtube.com/watch?v=Ef6MhjBKe-A

https://yoda.yale.edu/product-name/darzalex/

https://www.mayoclinic.org/drugs-supplements/daratumumab-intravenous-route/description/drg-20165230

https://www.prnewswire.com/news-releases/darzalex-daratumumab-based-regimens-significantly-improve-clinical-outcomes-in-both-transplant-eligible-and--ineligible-patients-who-are-newly-diagnosed-with-multiple-myeloma-302162312.html

https://ameripharmaspecialty.com/cancer/darzalex-and-its-role-in-treating-multiple-myeloma/

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/darzalex

https://www.medsafe.govt.nz/profs/datasheet/d/darzalexscinj.pdf

https://member.myhealthtoolkitks.com/web/public/brands/medicalpolicy/external-policies/daratumumab-darzalex-injection/

https://www.medicalnewstoday.com/articles/326582

https://www.globenewswire.com/news-release/2025/02/28/3034707/0/en/Johnson-Johnson-s-DARZALEX-daratumumab-subcutaneous-based-regimen-receives-positive-CHMP-opinion-for-patients-with-newly-diagnosed-multiple-myeloma-regardless-of-transplant-eligibi.html

https://finance.yahoo.com/news/darzalex-continues-redefine-multiple-myeloma-213100394.html

https://www.chemoexperts.com/daratumumab-darzalex.html

https://www.jnjmedicalconnect.com/products/darzalex/medical-content/use-of-darzalex-darzalex-faspro-in-newly-diagnosed-multiple-myeloma-in-patients-eligible-for-autolo

https://www.webmd.com/cancer/multiple-myeloma/darzalex-multiple-myeloma

https://ec.europa.eu/health/documents/community-register/2017/20170428137394/anx_137394_en.pdf

https://www.morningstar.com/news/pr-newswire/20250603ny01408/darzalex-faspro-daratumumab-and-hyaluronidase-fihj-based-regimen-shows-95-percent-progression-free-survival-at-four-years-in-transplant-eligible-newly-diagnosed-patients-with-multiple-myeloma-who-achieved-sustained-mrd-negativity

https://drugdocs.com/drug/darzalex

https://www.mysmarthealth.org/-/media/project/aca/mysmarthealth/pharmacy-documents/specialty-medications/daratumumab-darzalex-criteria-for-use.pdf

https://www.patientpower.info/video/multiple-myeloma/treatments/darzalex-faspro-what-is-it-and-does-it-have-side-effects

https://medicalxpress.com/news/2024-08-fda-darzalex-faspro-multiple-myeloma.html

https://www.biospace.com/another-win-for-darzalex-as-fda-approves-combination-treatment-for-multiple-myeloma

https://tnoncology.com/news/fda-approves-darzalex-for-patients-with-previously-treated-multiple-myeloma/

https://www.youtube.com/watch?v=-jsO4jSmJqE&pp=0gcJCdgAo7VqN5tD

https://finance.yahoo.com/news/analyses-reinforce-long-term-benefit-144800535.html

https://www.clinicaltrialsarena.com/marketdata/darzalex-daratumumab-treatment-multiple-myeloma/

https://www.jnjwithme.com/hcp/darzalex

https://www.cancerhealth.com/drug/darzalex

https://healthtree.org/myeloma/community/articles/darzalex-now-fda-approved-for-second-line-with-revdex-or-velcadedex

http://www.prnewswire.com/news-releases/daratumumab-darzalex-combined-with-standard-treatment-for-multiple-myeloma-produced-deep-and-durable-responses-in-relapsed-or-refractory-patients-300188611.html

http://www.multivu.com/players/English/7624051-janssen-darzalex-fda-approval/

https://www.finansavisen.no/borsmeldinger/2024/09/27/fe1f8df9-39f0-4e8c-adc7-5f4efc6bc597/darzalex-r-daratumumab-based-maintenance-regimens-show-clinically-meaningful-deep-and-durable-responses-in-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma

https://www.fox44news.com/business/press-releases/cision/20250603NY01408/darzalex-faspro-daratumumab-and-hyaluronidase-fihj-based-regimen-shows-95-percent-progression-free-survival-at-four-years-in-transplant-eligible-newly-diagnosed-patients-with-multiple-myeloma/

https://www.curetoday.com/view/adding-darzalex-to-standard-treatment-for-high-risk-multiple-myeloma-may-delay-disease-progression

https://www.specialtypharmacycontinuum.com/FDA-News/Article/07-24/FDA-Approves-Darzalex-Faspro-With-Bortezomib-Lenalidomide-and-Dexamethasone-for-Multiple-Myeloma/74442

https://www.globenewswire.com/news-release/2025/06/03/3092971/0/en/New-analyses-reinforce-long-term-benefit-of-DARZALEX-daratumumab-subcutaneous-based-quadruplet-regimen-for-patients-with-newly-diagnosed-multiple-myeloma.html

https://www.stocktitan.net/news/JNJ/darzalex-r-daratumumab-based-maintenance-regimens-show-clinically-x9z32mtvxtqv.html

https://www.biospace.com/fda-approves-darzalex-for-new-multiple-myeloma-indication

https://fox4kc.com/business/press-releases/cision/20241208NY74592/darzalex-faspro-daratumumab-and-hyaluronidase-fihj-based-regimens-demonstrate-improved-rates-of-minimal-residual-disease-mrd-negativity-and-progression-free-survival-in-patients-with-newly-d

https://www.goodrx.com/darzalex/what-is?srsltid=AfmBOooTTifEK90-yUNJyId9Dls30PgmOvrDXKJCJvuz_94miof1T_17

https://chemocare.com/druginfo/darzalex-faspro

https://www.cancerhealth.com/blog/fda-approves-darzalex-daratumumab-multiple-myeloma

https://www.youtube.com/watch?v=83jUzQBJ-I0

https://www.oncoprescribe.com/FDA-Approves-DARZALEX-in-Combination-with-POMALYST-and-Dexamethasone-for-Relapsed-or-Refractory-Multiple-Myeloma/

https://www.empr.com/drug/darzalex/

https://www.wnct.com/business/press-releases/cision/20241208NY74592/darzalex-faspro-daratumumab-and-hyaluronidase-fihj-based-regimens-demonstrate-improved-rates-of-minimal-residual-disease-mrd-negativity-and-progression-free-survival-in-patients-with-newly-d/

https://rarecancernews.com/news/fda-names-darzalex-breakthrough-therapy-for-previously-treated-multiple-myeloma/

https://www.youtube.com/watch?v=iCnKeqdr9RI&pp=0gcJCdgAo7VqN5tD

https://www.drugs.com/dosage/darzalex.html

https://www.southcarolinablues.com/web/public/brands/medicalpolicyih/external-policies/daratumumab-darzalex-injection/

https://www.patientpower.info/video/multiple-myeloma/ask-the-expert/how-is-daratumumab-used-to-treat-myeloma

https://www.youtube.com/watch?v=ft0bN4GJ4vA

https://biologicshq.com/product/darzalex/

https://www.jnjwithme.com/hcp/darzalex/support/

https://www.1mg.com/drugs/darzalex-injection-532505?srsltid=AfmBOopfdd0or-G2D6lSFBRAiDAhBNvx49tnYR7jIiH002O_XtD2Uk1D

https://www.cancernetwork.com/view/quarterly-mrd-monitoring-after-daratumumab-allows-relapse-detection-in-multiple-myeloma

https://www.1mg.com/drugs/darzalex-400mg-injection-530982?srsltid=AfmBOopHT21RwiIQaAKOjUB8Gq6gnRR0sZ3c6bNm9hjlpAmGAI0Bf6aU

https://www.jnjmedicalconnect.com/products/darzalex-faspro/medical-content/darzalex-darzalex-faspro-use-in-smoldering-multiple-myeloma

https://www.fiercepharma.com/pharma/eha-gsk-adds-fuel-adc-blenreps-comeback-case-new-pfs-data-ahead-potential-us-return

https://portal.sina.com.hk/finance/finance-globenewswire/globenewswire/2025/06/03/1203295/new-analyses-reinforce-long-term-benefit-of-darzalex-daratumumab-subcutaneous-based-quadruplet-regimen-for-patients-with-newly-diagnosed-multiple-myeloma/

https://www.youtube.com/watch?v=TQwqvujqDFU&pp=ygUQI3Z5a2l3ZGV2ZW50MjAyMg%3D%3D

https://www.onclive.com/view/early-daratumumab-in-patients-with-myeloma-experiencing-mrd-relapse-delays-clinical-progression

https://hidocdr.com/articles/19a850d9-d67d-438c-8d43-972c7b22af93

https://www.youtube.com/watch?v=Z7HfElR0ufw

https://ecancer.org/en/video/11893-daratumumab-plus-bortezomib-lenalidomide-dexamethasone-in-transplant-eligible-patients-with-ndmm-mrd-analysis

https://www.tradingview.com/news/zacks:b19e6365e094b:0-jnj-vs-mrk-which-healthcare-titan-offers-better-growth-prospects/

https://www.investing.com/news/transcripts/johnson--johnson-at-goldman-sachs-conference-strategic-growth-in-healthcare-93CH-4092075

https://www.youtube.com/watch?v=gz7WJhQFHPs

https://insights.citeline.com/scrip/r-and-d/clinical-trials/genmab-looks-to-keep-ahead-of-lilly-in-folate-adcs-PBMASYKTIRD5LFC2H4D7PVPXYQ/

https://pharmaphorum.com/news/nhs-starts-first-national-rollout-blenrep-myeloma

https://www.youtube.com/watch?v=mpiSaMj0kFY&pp=0gcJCdgAo7VqN5tD

https://www.thepharmaletter.com/biotechnology/english-first-to-access-blenrep-in-second-line-multiple-myeloma

https://www.cancernetwork.com/view/cilta-cel-demonstrates-curative-potential-in-r-r-multiple-myeloma

https://www.onclive.com/view/dr-dimopoulos-on-elranatamab-plus-daratumumab-and-lenalidomide-in-myeloma

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-jnj/johnson-johnson/news/daniel-pinto-joins-johnson-johnson-nysejnj-board-bringing-ex

https://www.youtube.com/watch?v=USzZrYbnHMA

https://quantisnow.com/insight/johnson-johnson-elects-daniel-pinto-president-jpmorganchase-to-its-board-of-directors-6080792